Hypotony maculopathy after filtering surgery with mitomycin C: Incidence and treatment

I. J. Suner, D. S. Greenfield, M. P. Miller, M. T. Nicolela, P. F. Palmberg, G. L. Skuta

Research output: Contribution to journalArticle

136 Scopus citations

Abstract

Purpose: Hypotony maculopathy after glaucoma filtering surgery with adjunctive mitomycin C has been reported to occur in 3% to 14% of cases. The authors evaluated its incidence when using a corneal safety-valve incision intended to reduce its occurrence. The authors also evaluated a technique for reversing hypotony maculopathy by reoperation using two sets of stitches in the scleral flap, with one set tied tightly to temporarily raise the intraocular pressure, stretch the sclera, and flatten chodoretinal folds. Methods: The authors reviewed the results of 699 procedures performed between April 1991 and October 1994. All were performed or supervised by one surgeon (PFP). Results: Hypotony maculopathy developed in 9 (1.3%) of 699 eyes. There was a statistically significant higher incidence in primary filters (4%) as compared to secondary filters or combined procedures. After revision, eight (89%) of nine recovered visual acuity of greater than or equal to 20/30 and the mean intraocular pressure was 14.5 ± 4 mmHg at a mean follow-up of 15 months. Conclusion: The incidence of hypotony maculopathy after glaucoma filtering surgery with mitomycin C using a corneal safety-valve incision is less than that reported in the literature without this incision. There is an increased risk in myopes, young patients, and primary filters. Early intervention with the described scleral flap revision technique usually allows restoration of prefiltration visual acuity without compromise of bleb function.

Original languageEnglish (US)
Pages (from-to)207-215
Number of pages9
JournalOphthalmology
Volume104
Issue number2
DOIs
StatePublished - Jan 1 1997

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Hypotony maculopathy after filtering surgery with mitomycin C: Incidence and treatment'. Together they form a unique fingerprint.

  • Cite this